Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01333722 · ClinicalTrials.gov registry record · Phase 2
Acute Pain Study Following Bunionectomy
A Phase 2 study, sponsored by AbbVie (prior sponsor, Abbott).
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT01333722 is a Phase 2 study that has completed, run by AbbVie (prior sponsor, Abbott). The registered enrollment target is 100 participants.
The verdict
NCT01333722, a Phase 2 study, has completed, sponsored by AbbVie (prior sponsor, Abbott).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
The primary purpose of this study was to evaluate analgesic efficacy and safety of hydrocodone/acetaminophen extended release compared to placebo in the treatment of moderate to severe pain following bunionectomy.
Interventions
- DRUG Placebo
- DRUG Hydrocodone/Acetaminophen Extended Release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01333722
The ClinicalTrials.gov registry entry for NCT01333722 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AbbVie (prior sponsor, Abbott), which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01333722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01333722 about?
NCT01333722 is a clinical study titled "Acute Pain Study Following Bunionectomy". The primary purpose of this study was to evaluate analgesic efficacy and safety of hydrocodone/acetaminophen extended release compared to placebo in the treatment of moderate to severe pain following bunionectomy.
What is the current status of trial NCT01333722?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2011-04. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01333722?
The interventions under investigation include: Placebo (DRUG), Hydrocodone/Acetaminophen Extended Release (DRUG).
Who is sponsoring clinical trial NCT01333722?
This trial is sponsored by AbbVie (prior sponsor, Abbott), which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.